J&J | Créanciers Commerciaux



Trade Creditors Changement Date
AbbVie 2.94B 2.66B 2024-12
Abbott USD 11.7B 8.8B 2024-12
Amgen USD 1.91B 239M 2024-12
AstraZeneca 22.46B 781M 2024-12
Baxter International USD 968M 127M 2024-12
Bayer EUR 7.52B 957M 2024-12
Becton, Dickinson and Co. USD 1.9B 255M 2024-09
Biogen USD 424.2M 1.5M 2024-12
Boston Scientific USD 960M 53M 2024-12
Bristol-Myers Squibb USD 3.6B 133M 2024-12
CONMED USD 102.25M 2.32M 2024-12
Cooper Companies USD 201.5M 59M 2025-01
Dexcom USD 345.3M 18.7M 2024-12
Edwards Lifesciences USD 197.4M 24.6M 2024-12
Eli Lilly USD 3.23B 342.1M 2024-12
Gilead Sciences USD 833M 70M 2024-12
GlaxoSmithKline 15.34B 960M 2024-12
Globus Medical USD 75.12M 17.58M 2024-12
Hologic USD 236.7M 32.9M 2024-12
Indivior 50M 4M 2024-09
Insulet USD 19.8M 20.5M 2024-12
Integra LifeSciences USD 82.5M 4.84M 2024-12
Intuitive Surgical USD 193.4M 25.3M 2024-12
J&J USD 10.31B 1.36B 2024-12
Medtronic USD 2.29B 90M 2025-01
Merck USD 4.08B 493M 2024-12
Merit Medical Systems USD 68.5M 7.69M 2024-12
Novartis USD 4.57B 485M 2024-12
Pfizer USD 5.63B 319M 2024-12
Regeneron Pharmaceuticals USD 4.89B 4.39B 2024-12
Roche Holding 4.35B 828M 2024-12
Sanofi 7.43B 105M 2024-06
Stryker USD 1.68B 342M 2024-12
Tandem Diabetes Care USD 44.73M 4.02M 2024-12
Teva Pharmaceutical Industries USD 2.2B 168M 2024-12
Vertex Pharmaceuticals USD 413M 17.2M 2024-12
Zimmer Biomet Holdings USD 194.6M 127.8M 2024-12
Zoetis USD 433M 29M 2024-12



J&J Créanciers Commerciaux - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.